Seattle Genetics studies monoclonal antibodies for Hodgkin’s disease

Interesting company that is studying the use of monoclonal antibodies for Hodgkin’s disease

Seattle Genetics: News Release.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s